New Medication for Lymphoma in Dogs

The FDA has granted full approval to verdinexor tablets (Laverdia; Anivive Lifesciences) for the treatment of dogs with lymphoma. The approval gives veterinarians a promising new oral avenue for managing the disease in dogs. Cancer cells can disable normal cellular growth regulation by driving tumor-suppressing proteins out of the nucleus. Verdinexor tablets target this system…

The post New Medication for Lymphoma in Dogs appeared first on Steve Dale Pet World.